M-14006 Herpes Simplex Virus Type II Test Kit

Diagnostic Significance: Genital herpes is a common sexually transmitted disease caused by Herpes Simplex Virus Type II (HSV-II), characterized by recurrent outbreaks and carcinogenic potential. Early diagnosis and treatment are crucial for promoting the healing of skin lesions, reducing its infectivity and harmful effects.
Clinical Department: Dermatovenereology Sample Collection: Epithelial cells from the base of the herpes lesion are collected. Product Features:
Antigen detection, which has significant clinical relevance.
Quick testing time, with results available within one hour.
Suitable for independent operation in dermatological laboratories. Note: Immunofluorescence is the recommended testing method by the Chinese Ministry of Health's industry standard WS 236-2003 "Diagnosis Standards and Treatment Principles for Genital Herpes."
Comparison of Various Testing Methods:
Method
Operability
Sensitivity
Specificity
Accuracy
PCR
Complex
Good
Average
Good
Cell Culture
Complex
Average
Good
Good
Immunofluorescence
Simple
Good
Good
Good
Test Kit Performance
-
95.20%
97.59%
97.09%
Note: The data for the Herpes Simplex Virus Type II test kit are derived from comparisons with similar commercially available test kits certified by the U.S. FDA.
Packaging Specifications: 50 tests per box
Storage Conditions and Shelf Life: Store in a dark, cool place at 2-8°C, with a shelf life of 14 months.
 
Usage Scenarios:
Dermatology and Venereology Departments: For diagnosing and monitoring genital herpes in patients, facilitating early treatment and management.
Hospitals and Clinics: For rapid and accurate testing of Herpes Simplex Virus Type II (HSV-II), providing timely results for patient care.
Diagnostic Laboratories: For routine screening and confirmation of genital herpes infections with high sensitivity and specificity.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic tools are widely used for managing sexually transmitted infections.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are expanding diagnostic capabilities for sexually transmitted diseases.
Global Health Programs: International health initiatives focused on improving the diagnosis and management of sexually transmitted infections in low-resource settings.